Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Dermatologic 1

Conditions

Melanoma 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Sarcoma 1Prostatic Neoplasms 1

Interventions

Flow Cytometry 4Cyclophosphamide 4Therapeutics 3Polymerase Chain Reaction 3Etoposide 3Carboplatin 3sargramostim 2liposomal amphotericin B 2aldesleukin 2Radiotherapy 2Psychiatric Rehabilitation 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Methylprednisolone 2Itraconazole 2Immunologic Techniques 2Dexamethasone 2Caspofungin 2Calcium Dobesilate 2Busulfan 2Aprepitant 2Amplified Fragment Length Polymorphism Analysis 2veliparib 1tremelimumab 1trastuzumab deruxtecan 1poly ICLC 1palbociclib 1fludarabine phosphate 1erythromycin propionate-N-acetylcysteinate 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Neoplasms × Histocompatibility Testing × Dermatologic × Clear all
NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Mayo Clinic

Terminated
13 enrolled
DermatologicGenitourinarySarcoma

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡